Prolonged hyperalimentation in catabolic chronic dialysis therapy patients

Area of Science:

• Nephrology
• Nutritional Science
• Biochemistry

Background:

• Chronic hemodialysis therapy (CDT) patients often experience weight loss and malnutrition.
• Assessing plasma amino acid profiles is crucial for understanding nutritional status in CDT patients.

Purpose of the Study:

• To evaluate the impact of specific amino acid (AA) hyperalimentation solutions on weight change and plasma amino acid profiles in CDT patients.
• To identify factors influencing the efficacy of nutritional interventions in catabolic CDT patients.

Main Methods:

• Measured plasma concentrations of 25 essential (EAA) and nonessential (NEAA) amino acids pre- and postdialysis in 46 CDT patients.
• Administered different amino acid and glucose solutions to subgroups of patients with prior weight loss.
• Compared outcomes with weight-stable, nonhyperalimented CDT patients.

Main Results:

• GAA hyperalimentation promoted weight gain in catabolic CDT patients with inadequate intake but not in those with advanced metabolic bone disease.
• EAA hyperalimentation with histidine led to weight gain but revealed NEAA deficits.
• Plasma phosphoethanolamine levels were elevated in catabolic CDT patients, suggesting a potential marker for catabolism.

Conclusions:

• GAA hyperalimentation can be beneficial for weight gain in specific CDT patient populations.
• Nutritional interventions need to be tailored to the patient's clinical status, particularly regarding metabolic bone disease.
• Optimized amino acid solutions and further investigation into markers like phosphoethanolamine are warranted for managing CDT-related malnutrition.